Compared with non-CLBC patients, younger people with less aggressive characteristics such as lower histologic grade, smaller tumor size, none or limited lymph node metastasis, and positive ER or PR status, or negative HER-2 in CLBC cohorts were more likely to receive mastectomy, instead of BCS. This evidence concerns the gene ERBB2 and metastatic malignant neoplasm in the lymph nodes.